GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Molnupiravir - LAGEVRIO capsules

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordAll source differencesRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Molnupiravir - UCSF adult renal guidance

Product / population
Adult institutional renal reference; eligibility and duration require the separate EUA source.
Renal method
Creatinine clearance, mL/min
Source revision
Revision not established in selected retrieval
Retrieved
2026-09-10
Local review status
Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Before use: Molnupiravir - LAGEVRIO capsules

UCSF prints >50 and <50, omitting exactly 50; the EUA renal instruction is not limited to those headings.

What to reconcile: Confirm the exact product, indication, renal measure and full source before prescribing.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Professional

Molnupiravir - UCSF adult renal guidance

Open original reference

UCSF Infectious Diseases Management Program · Adult institutional renal reference; eligibility and duration require the separate EUA source.

Renal method: Creatinine clearance, mL/min
Source date: Revision not established in selected retrieval
Retrieved: 2026-09-10

Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Before using this finding

Confirm the exact product, indication, renal measure and full source before prescribing.

Dialysis evidence: Qualified no-adjustment instruction; review dialysis evidence limits

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

Exactly 50 is not assigned by the printed >50 and <50 headings. No boundary is repaired by inference.

The page's all-indications shorthand does not establish EUA eligibility, treatment duration or pregnancy suitability.

UCSF printed non-dialysis bands
CrCl, mL/minSource-specific dose / instruction
>50800 mg orally every 12 hours
<50No renal adjustment
Dialysis guidance - separate source-specific schedules
UCSF molnupiravir dialysis
Dialysis setting / indicationSource-specific schedule
Intermittent HDNo renal adjustment
Continuous HDNo renal adjustment
Read the retained text before reformatting

UCSF printed non-dialysis bands

CrCl, mL/minSource-specific dose / instruction
>50800 mg orally every 12 hours
<50No renal adjustment

UCSF molnupiravir dialysis

Dialysis setting / indicationSource-specific schedule
Intermittent HDNo renal adjustment
Continuous HDNo renal adjustment

Exactly 50 is not assigned by the printed >50 and <50 headings. No boundary is repaired by inference.

The page's all-indications shorthand does not establish EUA eligibility, treatment duration or pregnancy suitability.

RDM63-professional-molnupiravir-5cf6929c23-C1 · Source locator: Adult non-dialysis and hemodialysis tables

Source-specific limits

Exactly 50 is not assigned by the printed >50 and <50 headings. No boundary is repaired by inference.

The page's all-indications shorthand does not establish EUA eligibility, treatment duration or pregnancy suitability.

Source identity and provenance
Source family
professional_guidance
Source
https://idmp.ucsf.edu/content/molnupiravir
Retrieved
2026-09-10
Renal-function method
Creatinine clearance, mL/min
Source date/version
Revision not established in selected retrieval
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
c5cfbec9668a89ab4d2f56fa5efb19fe8f7305d6e1c63fcbf8cf22667cf907bb

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=molnupiravir&s1=RDM63-professional-molnupiravir-5cf6929c23&h1=cf9d8b611051539efa9045276b182b26d516c07feee32a2a4a2180e38fe326a7